AAAAAA
Results:
1-12
|
Results: 12
Authors:
Marcus, PM
Fagerstrom, RM
Prorok, PC
Citation: Pm. Marcus et al., Re: Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up - Response, J NAT CANC, 93(4), 2001, pp. 322-322
Authors:
Marcus, PM
Bergstralh, EJ
Fagerstrom, RM
Williams, DE
Fontana, R
Taylor, WF
Prorok, PC
Citation: Pm. Marcus et al., Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up, J NAT CANC, 92(16), 2000, pp. 1308-1316
Authors:
Gohagan, JK
Prorok, PC
Hayes, RB
Kramer, BS
Citation: Jk. Gohagan et al., The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status, CONTR CL TR, 21(6), 2000, pp. 251S-272S
Authors:
Prorok, PC
Andriole, GL
Bresalier, RS
Buys, SS
Chia, D
Crawford, ED
Fogel, R
Gelmann, EP
Gilbert, F
Hasson, MA
Hayes, RB
Johnson, CC
Mandel, JS
Oberman, A
O'Brien, B
Oken, MM
Rafla, S
Reding, D
Rutt, W
Weissfeld, JL
Yokochi, L
Gohagan, JK
Citation: Pc. Prorok et al., Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 273S-309S
Authors:
O'Brien, B
Nichaman, L
Browne, JEH
Levin, DL
Prorok, PC
Gohagan, JK
Sullivan, D
Citation: B. O'Brien et al., Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, CONTR CL TR, 21(6), 2000, pp. 310S-328S
Authors:
Connor, RJ
Boer, R
Prorok, PC
Weed, DL
Citation: Rj. Connor et al., Investigation of design and bias issues in case-control studies of cancer screening using microsimulation, AM J EPIDEM, 151(10), 2000, pp. 991-998
Authors:
Hankey, BF
Feuer, EJ
Clegg, LX
Hayes, RB
Legler, JM
Prorok, PC
Ries, LA
Merrill, RM
Kaplan, RS
Citation: Bf. Hankey et al., Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates, J NAT CANC, 91(12), 1999, pp. 1017-1024
Authors:
Marcus, PM
Prorok, PC
Citation: Pm. Marcus et Pc. Prorok, Reanalysis of the Mayo Lung Project data: the impact of confounding and effect modification, J MED SCREE, 6(1), 1999, pp. 47-49
Authors:
Alexander, FE
Andriole, GL
Aus, G
Auvinen, A
Beensterboer, P
Blijenberg, BG
Bonardi, R
Buys, S
Candas, B
Ciatto, S
Crawford, ED
Demers, R
de Koning, HJ
Denis, L
Dijk, MA
Figueiredo, F
Gellman, EP
Gohagan, J
Hakama, M
Hugosson, J
Kirkels, WI
Kranse, R
van der Kwast, TH
Lilja, H
Maattanen, L
Mandel, J
Miller, AB
Monteiro, H
Nelen, V
Oberman, A
Paez, A
Prorok, PC
Reding, D
Rietbergen, JWBW
Rose, DB
Sanchez, AB
Schroder, FH
da Silva, EC
Simpson, N
Smith, PH
Stadaert, B
Stenman, UH
Teppo, L
Turkes, A
Weissfeld, JL
Yokochi, L
Citation: Fe. Alexander et al., Rationale for randomised trials of prostate cancer screening, EUR J CANC, 35(2), 1999, pp. 262-271
Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival
Authors:
Xu, JL
Fagerstrom, RM
Prorok, PC
Citation: Jl. Xu et al., Estimation of post-lead-time survival under dependence between lead-time and post-lead-time survival, STAT MED, 18(2), 1999, pp. 155-162
Authors:
Prorok, PC
Kramer, BS
Gohagan, JK
Citation: Pc. Prorok et al., Screening theory and study design: The basics, BAS CLIN ON, 18, 1999, pp. 29-53
Authors:
Xu, JL
Prorok, PC
Citation: Jl. Xu et Pc. Prorok, Estimating a distribution function of the tumor size at metastasis, BIOMETRICS, 54(3), 1998, pp. 859-864
Risultati:
1-12
|